Human Microbiome Therapeutics
Microbiome studies help explore treatments for genetic disorders
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
How buildings influence the microbiome and human health
Engineers develop innovative microbiome analysis software tools
FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome
Study finds microbiome changes dynamically and favors important host-relevant functions
Natural compounds in gut microbiome show promise for inflammation treatment
Gut microbiome: meet E coli – the infamous bacteria with an unfair reputation
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Microbiome
Microbiome studies help explore treatments for genetic disorders
World $2.5 Bn Human Microbiome Market Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030
Engineers develop innovative microbiome analysis software tools
Study finds microbiome changes dynamically and favors important host-relevant functions
Trio of scientists to unlock mystery, power of microbiome
Lifeway Foods® Applauds New Research Examining the Impact of Probiotics in Dairy Kefir on the Microbiome in Children with ADHD
FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome
The Long, Controversial Search for a 'Cancer Microbiome'
Father's gut microbiome may affect infant health
How buildings influence the microbiome and human health
Human Microbiome
World $2.5 Bn Human Microbiome Market Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030
Microbiome studies help explore treatments for genetic disorders
How buildings influence the microbiome and human health
Study finds microbiome changes dynamically and favors important host-relevant functions
The Human Microbiome and Aging: What’s the Latest Research?
Nutrition and Health: Human Microbiome
Natural compounds in gut microbiome show promise for inflammation treatment
Consumer microbiome startup Seed Health is rolling its profits into an AI science moonshot
The microbiome changes dynamically and favours important host-relevant functions
Microbiome Therapeutics
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Startup launched by 3 UC scientists, including husband of Nobel laureate Jennifer Doudna, hires CEO
Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptoms
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT